[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100553165":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":35,"locations":44,"responsibleParty":65,"collaborators":67,"id":73,"slug":25,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":25,"eligibilityCriteria":78,"healthyVolunteers":79,"sex":80,"minAge":81,"maxAge":25,"enrollmentInfo":82,"targetDuration":25,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":93,"whyStopped":25,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Levit Dermatology","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"5 billion exosome group","EXPERIMENTAL","This arm receives 5 billion WJMSC-exosome treatment on one side of the aforementioned treatment area and an equivalent volume of placebo on the contralateral half of the treatment area.",[13],"Combination Product: 5 billion exosomes and saline solution microneedling",{"label":15,"type":10,"description":16,"interventionNames":17},"50 billion exosome group","This arm receives 50 billion WJMSC-exosome treatment on one half of the aforementioned treatment area and an equivalent volume of placebo on the contralateral half of the treatment area.",[18],"Combination Product: 50 billion exosomes and saline solution microneedling",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"COMBINATION_PRODUCT","5 billion exosomes and saline solution microneedling","Participants will receive 5 billion WJMSC-exosome topical application on one half of the treatment area and an equivalent volume of saline solution on the contralateral half of the treatment area. Microneedling at a depth of .5mm on the entire treatment area will immediately follow the exosome and saline application. Participants will also receive 4 permanent microdot tattoos on the aforementioned locations.",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"50 billion exosomes and saline solution microneedling","Participants will receive 50 billion WJMSC-exosome topical application on one half of the treatment area and an equivalent volume of saline solution on the contralateral half of the treatment area. Microneedling at a depth of .5mm on the entire treatment area will immediately follow the exosome and saline application. Participants will also receive 4 permanent microdot tattoos on the aforementioned locations.",[15],[31],{"name":32,"affiliation":33,"role":34},"Eyal K Levit, M.D.","Owner and chief physician","PRINCIPAL_INVESTIGATOR",[36,40],{"name":32,"role":37,"phone":38,"phoneExt":25,"email":39},"CONTACT","917-868-5112","eyallevit@gmail.com",{"name":41,"role":37,"phone":42,"phoneExt":25,"email":43},"Nicholas L Gitsin","347-932-9894","nicholasgitsin8a@gmail.com",[45],{"facility":5,"status":25,"city":46,"state":47,"zip":48,"country":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Brooklyn","New York","11235","United States",{"type":51,"coordinates":52},"Point",[53,54],-73.94958,40.6501,{"lat":54,"lon":53},[57,59,60,61,64],{"name":58,"role":37,"phone":38,"phoneExt":25,"email":39},"Eyal K Levit, MD",{"name":41,"role":37,"phone":42,"phoneExt":25,"email":43},{"name":32,"role":34,"phone":25,"phoneExt":25,"email":25},{"name":62,"role":63,"phone":25,"phoneExt":25,"email":25},"Carla Mazzeo, M.Sc, Ph.D","SUB_INVESTIGATOR",{"name":41,"role":63,"phone":25,"phoneExt":25,"email":25},{"type":66,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[68,71],{"name":69,"class":70},"ResilielleTM Age ZeroTM Exosomes","UNKNOWN",{"name":72,"class":70},"Dorisca Research Consulting, LLC","100553165",false,"NCT06482541","Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia","1-Year Double-Blind Placebo-Controlled Study To EVALUATE THE EFFECT OF AGE ZERO™ EXOSOMES ON HAIR REGROWTH IN HEALTHY MEN AND WOMEN WITH ANDROGENETIC ALOPECIA","Inclusion Criteria:\n\n* Participant is experiencing hair loss and is diagnosed with Androgenetic Alopecia.\n\nExclusion Criteria:\n\n* Patients cannot have taken any medications, therapies, or treatment modalities of any kind to treat hair loss in the last six months.\n* Patients cannot have open wounds, eczema, or psoriatic plaques on the treatment area of the scalp.\n* Patients who are undergoing or have undergone chemotherapy and or radiation therapy within the past 6 months\n* Patients with a history of an autoimmune bullous disorder (having auto-antibodies to Dsg-1 or Dsg-3)\n* Patients who are currently immunocompromised or have a low white count making patients prone to infections.",true,"ALL","18 Years",{"count":83,"type":84},100,"ESTIMATED","INTERVENTIONAL",[87],"PHASE1","The purpose of this study is to determine whether Wharton's Jelly mesenchymal stem cell-derived exosome microneedling on the scalp is an effective treatment for Androgenetic Alopecia (pattern hair loss).",[90],"Androgenetic Alopecia",[92,90],"exosomes","NOT_YET_RECRUITING","2024-07-13",{"date":96,"type":97},"2024-07-16","ACTUAL",{"date":99,"type":84},"2024-07",{"date":101,"type":84},"2025-08",{"name":5,"class":6},1]